利润表（益丰药房）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 17,218,897,862.76 | 11,762,401,111.51 | 5,970,923,210.35 | 22,588,227,402.22 | 15,888,047,446.63 | 10,706,563,008.05 | 5,266,053,201.98 |
| 营业收入(元) | 17,218,897,862.76 | 11,762,401,111.51 | 5,970,923,210.35 | 22,588,227,402.22 | 15,888,047,446.63 | 10,706,563,008.05 | 5,266,053,201.98 |
| 二、营业总成本(元) | 15,712,009,022.92 | 10,676,892,508.96 | 5,394,533,467.59 | 20,616,597,464.58 | 14,471,700,283.74 | 9,723,036,449.52 | 4,782,809,738.38 |
| 营业成本(元) | 10,263,836,853.11 | 7,051,612,477.93 | 3,627,584,881.77 | 13,957,598,854.74 | 9,604,566,701.98 | 6,424,738,372.80 | 3,177,365,412.07 |
| 研发费用(元) | 25,185,648.10 | 16,865,821.99 | 9,772,260.99 | 33,549,984.91 | 15,256,402.00 | 9,857,000.57 | 4,637,452.27 |
| 营业税金及附加(元) | 69,011,236.33 | 48,210,499.54 | 23,137,102.99 | 89,389,002.35 | 57,658,655.79 | 37,592,754.20 | 17,915,105.74 |
| 销售费用(元) | 4,475,400,595.82 | 3,005,586,267.14 | 1,456,924,559.93 | 5,487,450,160.02 | 4,052,302,420.98 | 2,751,624,733.74 | 1,348,164,873.74 |
| 管理费用(元) | 756,145,104.20 | 481,533,402.41 | 249,116,315.31 | 962,424,859.48 | 678,908,209.66 | 459,894,841.53 | 214,580,647.02 |
| 财务费用(元) | 122,429,585.36 | 73,084,039.95 | 27,998,346.61 | 86,184,603.08 | 63,007,893.33 | 39,328,746.68 | 20,146,247.55 |
| 其中：利息费用(元) | 159,590,829.88 | 102,736,750.31 | 44,359,568.03 | 160,528,586.40 | 122,329,040.27 | 79,896,398.07 | 39,673,640.39 |
| 其中：利息收入(元) | 55,481,384.79 | 42,021,674.55 | 22,130,707.10 | 93,286,397.47 | 72,622,817.39 | 50,510,483.18 | 24,848,222.52 |
| 三、其他经营收益 | |||||||
| 加：投资收益(元) | 76,803,405.41 | 49,447,044.49 | 14,930,288.87 | 42,372,208.53 | 36,247,328.63 | 29,825,708.67 | 4,603,497.68 |
| 其中：对联营企业和合营企业的投资收益(元) | -974.75 | -903.14 | -453.88 | 316,574.96 | -1,600.53 | -1,563.03 | - |
| 资产处置收益(元) | 22,817,878.75 | 14,952,132.95 | 6,780,032.94 | 41,818,933.72 | 22,231,415.17 | 15,378,661.10 | 4,575,099.43 |
| 资产减值损失(元) | -59,754,324.50 | -38,797,603.61 | -19,301,520.80 | -72,633,545.68 | -53,458,692.66 | -34,609,009.50 | -16,876,815.01 |
| 信用减值损失(元) | -2,153,705.20 | -526,562.83 | 3,108,380.33 | -4,537,333.68 | 404,123.07 | 2,392,898.64 | 2,905,759.81 |
| 其他收益(元) | 40,942,345.23 | 23,383,714.37 | 11,615,548.55 | 76,134,913.66 | 47,045,163.20 | 36,216,238.02 | 23,203,122.40 |
| 四、营业利润(元) | 1,585,544,439.53 | 1,133,967,327.92 | 593,522,472.65 | 2,054,785,114.19 | 1,468,816,500.30 | 1,032,731,055.46 | 501,654,127.91 |
| 加：营业外收入(元) | 8,127,203.89 | 5,411,664.44 | 2,453,100.38 | 12,704,923.41 | 7,089,419.16 | 4,635,495.18 | 1,432,048.46 |
| 减：营业外支出(元) | 13,679,482.67 | 7,882,548.33 | 2,737,276.93 | 29,896,117.67 | 8,101,909.85 | 5,665,668.23 | 2,269,430.53 |
| 五、利润总额(元) | 1,579,992,160.75 | 1,131,496,444.03 | 593,238,296.10 | 2,037,593,919.93 | 1,467,804,009.61 | 1,031,700,882.41 | 500,816,745.84 |
| 减：所得税费用(元) | 381,573,694.73 | 271,425,909.71 | 147,286,412.75 | 456,662,974.49 | 339,535,380.16 | 232,838,824.73 | 120,947,089.80 |
| 六、净利润(元) | 1,198,418,466.02 | 860,070,534.32 | 445,951,883.35 | 1,580,930,945.44 | 1,128,268,629.45 | 798,862,057.68 | 379,869,656.04 |
| (一)按经营持续性分类 | |||||||
| 持续经营净利润(元) | 1,198,418,466.02 | 860,070,534.32 | 445,951,883.35 | 1,580,930,945.44 | 1,128,268,629.45 | 798,862,057.68 | 379,869,656.04 |
| (二)按所有权归属分类 | |||||||
| 归属于母公司股东的净利润(元) | 1,110,500,691.55 | 797,718,135.20 | 406,753,106.09 | 1,411,985,024.41 | 999,183,766.34 | 705,153,553.66 | 336,477,177.44 |
| 少数股东损益(元) | 87,917,774.47 | 62,352,399.13 | 39,198,777.26 | 168,945,921.03 | 129,084,863.11 | 93,708,504.02 | 43,392,478.59 |
| 扣除非经常性损益后的净利润(元) | 1,091,854,107.93 | 785,779,829.12 | 399,441,133.73 | 1,361,512,589.23 | 966,128,138.49 | 678,767,966.92 | 321,446,423.67 |
| 七、每股收益 | |||||||
| 一、基本每股收益(元) | 0.92 | 0.66 | 0.40 | 1.40 | 0.99 | 0.70 | 0.47 |
| 二、稀释每股收益(元) | 0.92 | 0.66 | 0.40 | 1.40 | 0.99 | 0.70 | 0.47 |
| 八、其他综合收益(元) | -89,370,675.00 | -119,801,550.00 | -44,204,850.00 | 38,418,418.54 | 84,865,543.54 | 157,579,318.54 | 90,606,909.49 |
| 归属于母公司股东的其他综合收益(元) | -89,370,675.00 | -119,801,550.00 | -44,204,850.00 | 38,418,418.54 | 84,865,543.54 | 157,579,318.54 | 90,606,909.49 |
| 九、综合收益总额(元) | 1,109,047,791.02 | 740,268,984.32 | 401,747,033.35 | 1,619,349,363.98 | 1,213,134,172.99 | 956,441,376.22 | 470,476,565.53 |
| 归属于母公司所有者的综合收益总额(元) | 1,021,130,016.55 | 677,916,585.20 | 362,548,256.09 | 1,450,403,442.95 | 1,084,049,309.88 | 862,732,872.20 | 427,084,086.93 |
| 归属于少数股东的综合收益总额(元) | 87,917,774.47 | 62,352,399.13 | 39,198,777.26 | 168,945,921.03 | 129,084,863.11 | 93,708,504.02 | 43,392,478.59 |
| 公告日期 | 2024-10-31 | 2024-08-30 | 2024-04-29 | 2024-04-29 | 2023-10-31 | 2023-08-30 | 2023-04-28 |
| 审计意见(境内) | 标准无保留意见 | ||||||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 其中：利息收入(元) |
| 三、其他经营收益 |
| 加：投资收益(元) |
| 其中：对联营企业和合营企业的投资收益(元) |
| 资产处置收益(元) |
| 资产减值损失(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 少数股东损益(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 八、其他综合收益(元) |
| 归属于母公司股东的其他综合收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 归属于少数股东的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 43 of 43 entries